Przejdź do zawartości
Merck

Przejdź do

453R-2

p53 (EP9) Rabbit Monoclonal Primary Antibody

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto

Informacje o tej pozycji

NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
EP9, monoclonal
Application:
IHC (p)
Citations:
9
Aby zapytać o ten produkt 453R-2, skontaktuj się z lokalnym biurem lub sprzedawcą firmy Merck. Skontaktuj się z zespołem ds. pomocy technicznej
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

culture supernatant

antibody product type

primary antibodies

clone

EP9, monoclonal

description

For In Vitro Diagnostic Use in Select Regions (See Chart)

form

buffered aqueous solution

species reactivity

human

packaging

vial of 0.1 mL concentrate (453R-24), vial of 0.1 mL concentrate Research Use Only (453R-24-RUO), vial of 0.5 mL concentrate (453R-25), bottle of 1.0 mL predilute ready-to-use (453R-27), vial of 1.0 mL concentrate (453R-26), vial of 1.0 mL concentrate Research Use Only (453R-26-RUO), vial of 1.0 mL pre-dilute Research Use Only (453R-27-RUO), bottle of 7.0 mL predilute ready-to-use (453R-28), vial of 7.0 mL pre-dilute ready-to-use Research Use Only (453R-28-RUO)

manufacturer/tradename

Cell Marque®

technique(s)

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:200 (concentrate)

control

breast carcinoma ((breast ductal carcinoma in-situ)), colorectal carcinoma, ovarian carcinoma ((ovarian serous carcinoma)), urothelial carcinoma

shipped in

wet ice

storage temp.

2-8°C

visualization

nuclear

Gene Information

human ... TP53(7157)

General description

Anti-p53 tumor suppressor protein antibody recognizes a 53 kDa phosphoprotein, identified as p53 suppressor gene product. It reacts with the mutant as well as wild type p53, although significant accumulation of the mutant form of p53 protein due to longer half-life is the basis for the test using the IHC technique.[1] Nuclear staining with this antibody has been shown in breast carcinoma, lung carcinoma, colorectal carcinoma, and urothelial carcinoma.[2][3][4][5][6][7][8]

Physical form

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

Preparation Note

Download the IFU specific to your product lot and format
Note: This requires a keycode which can be found on your packaging or product label.

Download the latest released IFU
Note: This IFU may not apply to your specific product lot

Analysis Note

United States - IVD
Canada - IVD
European Union - IVD
Japan - RUO

Other Notes

For Technical Service please contact: 800-665-7284 or email: [email protected]
p53 Positive Control Slides, Product No. 453S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

Legal Information

Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
05-224SAB5500157PLA0072
clone

EP9, monoclonal

clone

BP53-12, monoclonal

clone

SP5, monoclonal

clone

polyclonal

species reactivity

human

species reactivity

human

species reactivity

human (tested)

species reactivity

human

antibody form

culture supernatant

antibody form

purified immunoglobulin

antibody form

tissue culture supernatant

antibody form

affinity purified immunoglobulin

biological source

rabbit

biological source

mouse

biological source

rabbit

biological source

rabbit

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

shipped in

wet ice

shipped in

dry ice

shipped in

wet ice

shipped in

wet ice


Still not finding the right product?

Wypróbuj nasze narzędzie Narzędzie selektora produktów, aby zawęzić opcje.


Klasa składowania

12 - Non Combustible Liquids

wgk

WGK 2



Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów



Diagnostic Immunohistochemistry (Masson Publishing), Page 701-Page 702 (2006)
J K McKenney et al.
The American journal of surgical pathology, 25(8), 1074-1078 (2001-07-28)
Distinction of urothelial carcinoma in situ (CIS) from reactive atypia on the basis of morphology alone may be difficult in some cases. Because this distinction is therapeutically and prognostically critical, we attempted to determine if an immunohistochemical panel would help
David J Dabbs et al.
The American journal of surgical pathology, 37(7), e1-11 (2013-06-14)
Lobular neoplasia (LN) is a term that encompasses both lobular carcinoma in situ and atypical lobular hyperplasia. These lesions have been shown to constitute both risk indicators and nonobligate precursors of invasive breast cancer, they are relatively uncommon, and are



Numer pozycji handlu globalnego

SKUNUMER GTIN
453R-2404061837571701
453R-2604061837571749
453R-24-RUO04061837571718
453R-28-RUO04061837571794
453R-2704061837571763
453R-25-RUO04061837571732
453R-2504061837571725
453R-2804061837571787
453R-27-RUO04061837571770
453R-26-RUO04061837571756

Questions

Reviews

No rating value

Active Filters